Withdrawal of Prexige (lumiracoxib)
Cox 2 inhibitor, Prexige (lumiracoxib) is no longer available in Australia. Novartis
Pharmaceuticals Australia has withdrawn all strengths of Prexige (lumiracoxib) following
cancellation of its registration by the Therapeutic Goods Administration (TGA).
The listing for Prexige (lumiracoxib) tablets in the Schedule of Pharmaceutical Benefits
will be removed as soon as possible, on 1 October 2007.
For further information regarding the withdrawal of Prexige (lumiracoxib) visit the TGA website.
